Although CD40L is a marker of platelet and T-cell activation, the major source of CD40L present in plasma is derived from platelet, thereby the increase of CD40L here suggested that platelet activation might be an important factor in the pathophysiology of COVID-19–associated coagulopathy and might accelerate the progression of disease. Here, CD40LG is linked to blood coagulation disease.